MedPath

Novarel

NOVAREL (chorionic gonadotropin) for injection, for intramuscular use Initial U.S. Approval: 1974

Approved
Approval ID

ac6918ff-9dc3-40d9-8619-54b26e4bdfc8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 5, 2023

Manufacturers
FDA

Ferring Pharmaceuticals Inc.

DUNS: 103722955

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

gonadotrophin, chorionic

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55566-1502
Application NumberBLA017016
Product Classification
M
Marketing Category
C73585
G
Generic Name
gonadotrophin, chorionic
Product Specifications
Effective DateJune 5, 2023
FDA Product Classification

gonadotrophin, chorionic

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55566-1501
Application NumberBLA017016
Product Classification
M
Marketing Category
C73585
G
Generic Name
gonadotrophin, chorionic
Product Specifications
Effective DateJune 5, 2023
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.